VN August 2022
Vetnuus | August 2022 18 As professionals working in theVeterinary Sector - What should the Science and Experiences of Covid have taught us? Part 1 Dr Neil A Forbes BVetMed DipECZM(avian) FRCVS Covid has focused many minds on infection control, biosecurity, zoonosis and nosocomial infections, which is undoubtedly good. If anything positive can come from the pandemic, perhaps it might act as a ‘light bulb moment’, just as cleanliness was to Florence Nightingale somany years ago, as well as in teaching us all some valuable and uncomfortable home truths. Covidwas not the first, nor will it be the last global pandemic. All of us in health care sectors have a duty of care to patients, staff and populations alike to undertake basic infection control procedures. As references demonstrate, we cannot rely on human cleaning and disinfection in busy clinical settings. We must use methods and techniques that can run simultaneously with‘on-going clinical activities’, that are proven safe (for patients, staff and the environment) and appropriate (to national or international standards) to match the requirements of that specific clinical setting. We must test andmeasureoutcomes and recordand investigatenosocomial andzoonotic incidents.Wemust continue to learn and improve. COVID Now that it seems most likely that the infection was derived from bats in a ‘wet market’ in Wuhan, China (Haider et al. 2020), we are reminded that differing inpatients and out-patients each carry a variable endemic contagion risk to our facilities, staff and other patients (Wright et al. 2008). Patients should be assessed andmanaged on a contagion and infection risk control basis at all stages of their journey through our facility. Covid is not the first, nor will it be the last zoonotic pandemic infection. Scientists estimate that more than 60% of known infectious diseases can be spread from animals, and 75% of new or emerging infectious diseases in people come from animals. They can be distributed in several ways, including direct or indirect contact, vector-borne, foodborne or waterborne (MSD 2021). Covid has been a timely reminder that in these days of globalisation, high population densities and frequent international travel, infection and contagion control must be considered in a global sense, in which the weakest link in the chain creates themost significant risk. As veterinarians – clinicians, and business owners, we have a duty to our clients and businesses to maintain effective control of contagious infections (both those we know about now, as well as those that are unknown). Such infections are not only a danger to our clients, patients, staff and business, but sick animals are accepted to be the source of 75% of new emerging infectious diseases in humans (MSD 2021). Whilst we have all been focusing on Covid-19, Laximinarayan (2022) reminds us of the ‘forgotten pandemic of anti-microbial infection’. Laximinarayan quotes Murray (2022) in estimating 1.27 million human deaths globally due to Anti- Microbial Resistance in 2019, a figure which is almost identical to the combined global deaths over the same period caused by HIV and Malaria, whilst WHO figures (November 2019 to January 2022) for Covid-19 are four times higher, all be it over amore extended period. ANTI-MICROBIAL RESISTANCE (AMR) Despite all the hype of the last five years, the recent Lancet publication (Laximinarayan 2022) demonstrates clearly that AMR is a silent pandemic. It is killing more people than Malaria or AIDS. It is close to Covid-19, so despite the infection control measures thrust upon us by the experience of Covid, we are still failing to meet the challenges of infection control and hence as a spin- off, of the AMR pandemic. The responsible use of antibiotics is essential, but more importantly, we must continue the drive to reduce the requirement for antibiotics by improving animal husbandry (particularly in food-producing species). It can only be achieved by improved biosecurity and infection control, improved standard operating procedures, better cleaning, disinfection and the monitoring of the infection control outcomes Whilst we have all been excited and focused on Covid, we are reminded that in recentyearstheincidenceofnosocomialinfectionsinhumansafterhospitalvisits was outed as a scandal (Boyce 2016). However, the incidence in human hospitals has beendrastically reducedby applyingan‘effectivedisinfectant’delivered inan aerosolised form (fogging). Gebel et al. (2013) confirmed the role of contaminated surfaces in transmitting pathogenic microorganisms causing healthcare-acquired infections. White et al. (2007) demonstrated that detergent cleaning reduces the bacterial load by 80% from surfaces. Disinfectant cleaning does not generally maintain a surface pathogen free for any longer than detergent alone (Dharan et a.l 1999), whilst a ‘two-stage cleaning’, with detergent removal of bioload, followed by disinfectant treatment achieved the best results overall. Moreover, laboratory evidence suggests that biocides used at a sub-lethal concentration may trigger the expression of biocide resistance and/or select bacteria resistant to antibiotics (Maillard & Denyer 2009, Karatzas et al. 2008). In light of this, biocides are not recommended for use in situations where environmental conditions will compromise their efficacy, i.e. where excessive organicmaterial remains present, as the cleaning has not been undertaken before disinfection. Unannounced cleanliness audits in human hospitals using bacterial swab culture (Anderson et al. 2011) showed 86.8% hygiene failure, whilst using adenine triphosphate (ATP) testing (a much quicker system with results being made available immediately ‘patient side’yielded hygiene failures of 84% (Schabrun & Chipchase 2006). Post- cleaning hygiene monitoring using fluorescent markers, ATP or microbiological testing has proven valuable in improving cleaning efficacy (Carling et a.l 2016). Dancer (2012) demonstrated that simple infection control procedures are abandoned, ignored, or forgotten when staff are overworked in demanding clinical situations. Indeed, all hygienic practices are consistently challenged in a busy ward. For this reason, using fogging with effective anti-microbial solutions is beneficial. However, no one should ignore the need for the regular use of detergents to remove organic material before disinfection. Byrns and Fuller (2011) trialled various methods of aerolisation of biocides for sterilising spaces in buildings. Where effective biocidal agents were applied, they reported high levels of efficacy, particularly noting the benefit of reaching and penetrating areas that would not otherwise be sanitised. However, the technique is not universally recommended unless the agent is safe for staff and patients or in situations where the facility can be emptied before application. Many fogging agentscanonlybeusedwhenclinicalareasareemptyofpatientsandstaff,which inevitably limits their application, especially in facilities with multiple patients that are rarely empty. In contrast, optimal efficacy is achieved when fogging is done using effective agents that can safely be used with either patients or staff in situ. However, few anti-microbial solutions meet these exacting requirements (effectiveness and safety). Some disinfectant compounds comprising of a surfactant plus an anti-microbial substance, such as quaternary ammonium compounds (QAC) (of which there are now six generations, with sequential advances just as seen in penicillins or cephalosporins), are designed to minimise bacterial contamination of surfaces by maintaining their anti-microbial activity on surfaces for weeks or months. These compounds’ ability to prevent surface contamination for prolonged periods is unclear. Two studies have reported persistent anti-microbial activity of varying levels for differing periods (Baxa et al., 2011, Tamimi et al .2014). Further evaluation of organosilane-type compounds using a variety of application methods appears warranted. Polyhexamethylene biguanide disinfectant was
Made with FlippingBook
RkJQdWJsaXNoZXIy OTc5MDU=